Literature DB >> 9182024

[Percutaneous dilatative tracheostomy as a new method in intensive medicine. Procedure, advantages and risks].

T M Treu1, M Knoch, N Focke, M Schulz.   

Abstract

BACKGROUND AND
OBJECTIVE: Percutaneous dilatational tracheostomy (PDT) is a recently developed method to obtain endotracheal access, also at the bed-side, in ventilated patients. The procedure is described and results are presented. PATIENTS AND METHODS: PDT was performed in 112 patients (82 men, 30 women, average age 50.7 years) between 1.5. 1994 and 31.5. 1996, in all cases expected to require more than 10 days of assisted ventilation. All complications, late sequelae and cosmetic results after decannulation were analysed.
RESULTS: No serious complications were noted during the procedure. Erroneous puncture occurred in nine patients, but were corrected without problem. Complications necessitating temporary interruption of the tracheostomy consisted of accidental extubation and ventilatory problems (two patients each). There were no late sequelae and the cosmetic results were judged to be very good.
CONCLUSION: PDT is a simple and relatively easily learned procedure. It has a low complication rate, late sequelae are very rare and cosmetic results after closure of the tracheostomy are excellent.

Entities:  

Mesh:

Year:  1997        PMID: 9182024     DOI: 10.1055/s-2008-1047661

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Experience with two different techniques of percutaneous dilational tracheostomy in 54 neurosurgical patients.

Authors:  Wolfgang Börm; Markus Gleixner
Journal:  Neurosurg Rev       Date:  2003-02-01       Impact factor: 3.042

2.  Comparison of EtView™ tracheoscopic ventilation tube and video-assisted fiberoptic bronchoscopy during percutaneous dilatational tracheostomy.

Authors:  Tarik Umutoglu; Mefkur Bakan; Ufuk Topuz; Sinan Yilmaz; Kadir Idin; Selcuk Alver; Erdogan Ozturk; Ziya Salihoglu
Journal:  J Clin Monit Comput       Date:  2016-04-29       Impact factor: 2.502

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.